Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tabalumab |
Trade Name | |
Synonyms | LY2127399 |
Drug Descriptions |
Tabalumab (LY2127399) is a monoclonal antibody that neutralizes B-cell activating factor (BAFF), resulting in decreased development of osteoclasts and thus, potential antitumor activity (PMID: 27287072, PMID: 28005265). |
DrugClasses | |
CAS Registry Number | 1143503-67-6 |
NCIT ID | C91727 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bortezomib + Tabalumab | Bortezomib Tabalumab | 0 | 0 |
Tabalumab | Tabalumab | 0 | 0 |